The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery

Exclusion Criteria

• •1. Any history of arterial or venous thrombosis, including partial or complete thrombosis;
• •2. Evidence of thrombosis (partial or complete) in the main portal vein, portal vein branches, or any part of the splenic mesenteric system at Screening;
• •3. Portal vein blood flow velocity rate \<10 centimeters/second at Screening;
• •4. There are other diseases that may cause thrombocytopenia.